GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) » Definitions » Price-to-Operating-Cash-Flow

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Price-to-Operating-Cash-Flow : 13.52 (As of May. 12, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Harbin Gloria Pharmaceuticals Co Price-to-Operating-Cash-Flow?

As of today (2024-05-12), Harbin Gloria Pharmaceuticals Co's share price is ¥2.15. Harbin Gloria Pharmaceuticals Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.16. Hence, Harbin Gloria Pharmaceuticals Co's Price-to-Operating-Cash-Flow Ratio for today is 13.52.

The historical rank and industry rank for Harbin Gloria Pharmaceuticals Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

SZSE:002437' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.1   Med: 21.15   Max: 533.33
Current: 13.44

During the past 13 years, Harbin Gloria Pharmaceuticals Co's highest Price-to-Operating-Cash-Flow Ratio was 533.33. The lowest was 5.10. And the median was 21.15.

SZSE:002437's Price-to-Operating-Cash-Flow is ranked better than
61.24% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.73 vs SZSE:002437: 13.44

Harbin Gloria Pharmaceuticals Co's Cash Flow from Operations per share for the three months ended in Mar. 2024 was ¥0.07. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.16.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Harbin Gloria Pharmaceuticals Co was 25.20% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 175.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -17.50% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -15.30% per year.

During the past 13 years, Harbin Gloria Pharmaceuticals Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 175.20% per year. The lowest was -72.80% per year. And the median was 7.90% per year.


Harbin Gloria Pharmaceuticals Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Harbin Gloria Pharmaceuticals Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harbin Gloria Pharmaceuticals Co Price-to-Operating-Cash-Flow Chart

Harbin Gloria Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.90 533.33 23.28 21.34 20.08

Harbin Gloria Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.90 14.97 16.50 20.08 13.46

Competitive Comparison of Harbin Gloria Pharmaceuticals Co's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Gloria Pharmaceuticals Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harbin Gloria Pharmaceuticals Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harbin Gloria Pharmaceuticals Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Harbin Gloria Pharmaceuticals Co's Price-to-Operating-Cash-Flow falls into.



Harbin Gloria Pharmaceuticals Co Price-to-Operating-Cash-Flow Calculation

Harbin Gloria Pharmaceuticals Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=2.15/0.159
=13.52

Harbin Gloria Pharmaceuticals Co's Share Price of today is ¥2.15.
Harbin Gloria Pharmaceuticals Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.16.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Harbin Gloria Pharmaceuticals Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Harbin Gloria Pharmaceuticals Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Harbin Gloria Pharmaceuticals Co (SZSE:002437) Business Description

Traded in Other Exchanges
N/A
Address
Beijing Road No 29, Harbin Economic and Technological Development Zone, Harbin, CHN, 150025
Harbin Gloria Pharmaceuticals Co Ltd is a tech biopharmaceutical enterprise. It is engaged in the research, development, production, and sale of pharmaceutical products primarily in China. The company offers cardiovascular drugs; cardiac cerebrovascular medication; vitamins and minerals; urinary tract drugs; urinary system medication; anti-tumor medication; endocrine system drugs; anti-infective drugs; digestive system medication; respiratory medication; and other medications.

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Headlines

No Headlines